-- 根据FactSet调查的分析师数据，Marsh & McLennan (MRSH) 的平均评级为“持有”，平均目标价为203.95美元。 （报道北美、亚洲和欧洲主要银行及研究机构的股票、商品和经济研究。研究机构可通过以下链接联系我们：https://www..com/contact-us）
Price: $170.06, Change: $+1.91, Percent Change: +1.14%
Related Articles
Asia
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.
$ASX:XRF
Asia
Sprintex Raising AU$1.1 Million Via Convertible Notes Issue
Sprintex (ASX:SIX) is raising about AU$1.1 million through the issue of nearly 1.1 million convertible notes at a price of AU$1 each, according to a Monday filing with the Australian bourse.The notes will mature on June 30, 2027, and bear interest at 8% per year, per the filing.Holders of the notes can convert them into Sprintex ordinary shares at any time after June 30 and before their maturity.The company said it plans to use the funds for general working capital purposes, to expand its sales team, and to fulfill customer orders.
$ASX:SIX
Asia
Immutep Says Bank of New York Mellon Increases Stake
Immutep (ASX:IMM) received notice that Bank of New York Mellon and its affiliated entities increased their holdings in the company to 21.11% from 20.08%, according to a Monday filing with the Australian bourse.Bank of New York Mellon and its affiliates now owns over 311 million shares in the company, the filing said.
$ASX:IMM